A randomised controlled trial of triple antiplatelet therapy (aspirin, clopidogrel and dipyridamole) in the secondary prevention of stroke: safety, tolerability and feasibility.

A randomised controlled trial of triple antiplatelet therapy (aspirin, clopidogrel and dipyridamole) in the secondary prevention of stroke: safety, tolerability and feasibility.

<h4>Background</h4>Aspirin, dipyridamole and clopidogrel are effective in secondary vascular prevention. Combination therapy with three antiplatelet agents might maximise the benefit of antiplatelet treatment in the secondary prevention of ischaemic stroke.<h4>Methodology/principal...

Full description

Saved in:
Bibliographic Details
Main Authors: Nikola Sprigg, Laura J Gray, Tim England, Mark R Willmot, Lian Zhao, Gillian M Sare, Philip M W Bath
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2008-08-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0002852&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items